APA (7th ed.) Citation

Park, S., Park, J. M., Park, M., Ko, D., Kim, S., Seo, J., . . . Seo, J. H. (2022). β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features. Cancer Cell International, 22(1), 1. https://doi.org/10.1186/s12935-022-02713-9

Chicago Style (17th ed.) Citation

Park, Soeun, et al. "β-Escin Overcomes Trastuzumab Resistance in HER2-positive Breast Cancer by Targeting Cancer Stem-like Features." Cancer Cell International 22, no. 1 (2022): 1. https://doi.org/10.1186/s12935-022-02713-9.

MLA (9th ed.) Citation

Park, Soeun, et al. "β-Escin Overcomes Trastuzumab Resistance in HER2-positive Breast Cancer by Targeting Cancer Stem-like Features." Cancer Cell International, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12935-022-02713-9.